Patents by Inventor Valérie Corp dit Genti

Valérie Corp dit Genti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210301027
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: February 24, 2021
    Publication date: September 30, 2021
    Inventors: Preethi Aavali Sridhara Sundaram, Ronald Buggage, Karen W. Chu, Valérie Corp dit Genti, Kristine A. Erickson, Dominique Mery-Mignard, Rafael Varona, Robert L. Vitti
  • Patent number: 10968278
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: April 6, 2021
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Preethi Aavali Sridhara Sundaram, Ronald Buggage, Karen W. Chu, Valérie Corp dit Genti, Kristine A. Erickson, Dominique Mery-Mignard, Rafael Varona, Robert L. Vitti
  • Publication number: 20170166646
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: November 3, 2016
    Publication date: June 15, 2017
    Inventors: Preethi Aavali Sridhara Sundaram, Ronald Buggage, Karen W. Chu, Valérie Corp dit Genti, Kristine A. Erickson, Dominique Mery-Mignard, Rafael Varona, Robert L. Vitti